FI120537B - Trisubstituoituja fenyylijohdannaisia - Google Patents

Trisubstituoituja fenyylijohdannaisia Download PDF

Info

Publication number
FI120537B
FI120537B FI973440A FI973440A FI120537B FI 120537 B FI120537 B FI 120537B FI 973440 A FI973440 A FI 973440A FI 973440 A FI973440 A FI 973440A FI 120537 B FI120537 B FI 120537B
Authority
FI
Finland
Prior art keywords
formula
hydroxy
alkyl
compounds
carbon atoms
Prior art date
Application number
FI973440A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973440A (fi
FI973440A0 (fi
Inventor
Peter Nussbaumer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9505080.3A external-priority patent/GB9505080D0/en
Priority claimed from GBGB9505858.2A external-priority patent/GB9505858D0/en
Priority claimed from GBGB9526593.0A external-priority patent/GB9526593D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI973440A0 publication Critical patent/FI973440A0/fi
Publication of FI973440A publication Critical patent/FI973440A/fi
Application granted granted Critical
Publication of FI120537B publication Critical patent/FI120537B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI973440A 1995-03-14 1997-08-21 Trisubstituoituja fenyylijohdannaisia FI120537B (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB9505080 1995-03-14
GBGB9505080.3A GB9505080D0 (en) 1995-03-14 1995-03-14 Organic compounds
GBGB9505858.2A GB9505858D0 (en) 1995-03-23 1995-03-23 Organic Compounds
GB9505858 1995-03-23
GB9526593 1995-12-28
GBGB9526593.0A GB9526593D0 (en) 1995-12-28 1995-12-28 Organic compounds
EP9601116 1996-03-14
PCT/EP1996/001116 WO1996028430A1 (en) 1995-03-14 1996-03-14 Trisubstituted phenyl derivatives

Publications (3)

Publication Number Publication Date
FI973440A0 FI973440A0 (fi) 1997-08-21
FI973440A FI973440A (fi) 1997-10-24
FI120537B true FI120537B (fi) 2009-11-30

Family

ID=27267624

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973440A FI120537B (fi) 1995-03-14 1997-08-21 Trisubstituoituja fenyylijohdannaisia

Country Status (24)

Country Link
US (1) US5990116A (cs)
EP (1) EP0815087B1 (cs)
JP (1) JP3194963B2 (cs)
KR (1) KR100437580B1 (cs)
CN (1) CN1101386C (cs)
AT (1) ATE208763T1 (cs)
AU (1) AU704544B2 (cs)
BR (1) BR9607240A (cs)
CA (1) CA2214131C (cs)
CZ (1) CZ289944B6 (cs)
DE (1) DE69616993T2 (cs)
DK (1) DK0815087T3 (cs)
ES (1) ES2168463T3 (cs)
FI (1) FI120537B (cs)
HK (1) HK1014440A1 (cs)
HU (1) HUP9801828A3 (cs)
MX (1) MX9707022A (cs)
NO (1) NO310356B1 (cs)
NZ (1) NZ304291A (cs)
PL (1) PL185875B1 (cs)
PT (1) PT815087E (cs)
RU (1) RU2164224C2 (cs)
SK (1) SK282155B6 (cs)
WO (1) WO1996028430A1 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747498A (en) 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
US6706721B1 (en) 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
UA71945C2 (en) 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
JP3270834B2 (ja) 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク 抗がん剤として有用なヘテロ芳香族二環式誘導体
US7087613B2 (en) 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
UA74803C2 (uk) 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
KR100819716B1 (ko) * 2000-04-07 2008-04-07 칫소가부시키가이샤 신규한 디아미노 화합물, 당해 디아미노 화합물을사용하여 합성된 중합체, 및 당해 중합체를 사용하는니스, 배향막 및 액정 표시소자
MXPA04002537A (es) * 2001-10-12 2004-05-31 Warner Lambert Co Alquinos como inhibidores de metaloproteinasa de matriz.
AU2002366103A1 (en) * 2001-11-19 2003-06-10 Iconix Pharmaceuticals, Inc. Modulators of rho c activity
JP2006502114A (ja) * 2002-07-17 2006-01-19 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー マトリクスメタロプロテイナーゼ−１３のアロステリックアルキン阻害薬とセレコキシブまたはバルデコキシブとの組合せ
AU2003281168A1 (en) * 2002-07-17 2004-02-02 Warner-Lambert Company Llc Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib
AU2003249539A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
GB0319497D0 (en) * 2003-08-19 2003-09-17 Novartis Ag Organic compounds
SE0400234D0 (sv) * 2004-02-06 2004-02-06 Active Biotech Ab New compounds, methods for their preparation and use thereof
WO2005091891A2 (en) * 2004-03-11 2005-10-06 Kythera Biopharmaceuticals, Inc. Compositions and methods for preventing and treating skin and hair conditions
US20080031898A1 (en) * 2004-03-26 2008-02-07 David Nathaniel E Compositions and methods to increase the effect of a neurotoxin treatment
GB0412769D0 (en) * 2004-06-08 2004-07-07 Novartis Ag Organic compounds
BRPI0514051B1 (pt) * 2004-08-04 2014-07-22 Nippon Kayaku Kk Composto derivado de quinolina que compreende o mesmo como ingrediente ativo, inseticida, método e uso destes no controle de pragas de insetos na agricultura e horticultura
WO2008044688A1 (fr) * 2006-10-11 2008-04-17 Daiichi Sankyo Company, Limited Dérivé de l'urée
CA2677457A1 (en) * 2007-02-06 2008-08-14 Helen Tuvesson Andersson New compounds, methods for their preparation and use thereof
US20210017174A1 (en) 2018-03-07 2021-01-21 Bayer Aktiengesellschaft Identification and use of erk5 inhibitor
WO2021026672A1 (en) * 2019-08-09 2021-02-18 Novartis Ag Heterocyclic wdr5 inhibitors as anti-cancer compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5651423A (en) * 1979-09-13 1981-05-09 Wellcome Found Antiviral agent
CA1219587A (en) * 1981-12-14 1987-03-24 Norman P. Jensen Hydroxybenzylaminobenzenes as anti-inflammatory agents
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
JPH01501790A (ja) * 1986-11-19 1989-06-22 ケメックス　ファーマシューティカルズ，インコーポレイティド リポキシゲナーゼ阻害剤
WO1988003806A1 (en) * 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Pharmacologically active compositions of catecholic butanes with zinc
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US5272167A (en) * 1986-12-10 1993-12-21 Schering Corporation Pharmaceutically active compounds
KR920701167A (ko) * 1989-07-07 1992-08-11 에릭 에스. 딕커 약제학적 활성 화합물
HUT60458A (en) * 1991-02-01 1992-09-28 Sandoz Ag Process for producing benzyloxyphenyl derivatives and pharmaceutical compositions comprising same
ES2108120T3 (es) * 1991-05-10 1997-12-16 Rhone Poulenc Rorer Int Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf.
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
GB9121943D0 (en) * 1991-10-16 1991-11-27 Sandoz Ltd Organic compounds,processes for their production and their use
US5656643A (en) * 1993-11-08 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Also Published As

Publication number Publication date
CA2214131C (en) 2009-06-23
DE69616993D1 (de) 2001-12-20
JPH11503412A (ja) 1999-03-26
EP0815087A1 (en) 1998-01-07
CN1183774A (zh) 1998-06-03
ES2168463T3 (es) 2002-06-16
HK1014440A1 (en) 1999-09-30
DK0815087T3 (da) 2002-03-11
CZ286997A3 (en) 1997-12-17
ATE208763T1 (de) 2001-11-15
SK282155B6 (sk) 2001-11-06
EP0815087B1 (en) 2001-11-14
NO310356B1 (no) 2001-06-25
BR9607240A (pt) 1997-11-11
US5990116A (en) 1999-11-23
AU704544B2 (en) 1999-04-29
CN1101386C (zh) 2003-02-12
CA2214131A1 (en) 1996-09-19
PL322134A1 (en) 1998-01-05
DE69616993T2 (de) 2002-07-04
NO974118D0 (no) 1997-09-08
MX9707022A (es) 1998-06-30
RU2164224C2 (ru) 2001-03-20
PL185875B1 (pl) 2003-08-29
FI973440A (fi) 1997-10-24
HUP9801828A3 (en) 2001-02-28
NZ304291A (en) 1999-01-28
FI973440A0 (fi) 1997-08-21
KR100437580B1 (ko) 2004-07-16
KR19980703049A (ko) 1998-09-05
HUP9801828A2 (hu) 1999-03-29
AU5144396A (en) 1996-10-02
SK124597A3 (en) 1998-01-14
CZ289944B6 (cs) 2002-04-17
NO974118L (no) 1997-09-08
JP3194963B2 (ja) 2001-08-06
WO1996028430A1 (en) 1996-09-19
PT815087E (pt) 2002-04-29

Similar Documents

Publication Publication Date Title
FI120537B (fi) Trisubstituoituja fenyylijohdannaisia
CA2724077C (en) Amide compound
AP795A (en) Indazole derivatives.
ES2416289T3 (es) Nuevo derivado de 1,2-dihidroquinolina que tiene como sustituyentes un grupo alquilo inferior sustituido con fenilcalcógeno y un grupo fenilo introducido por un éster
EP3154954B1 (en) Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereof
JP4571863B2 (ja) 抗痛覚過敏剤として有用なキナゾリノン誘導体
EP0706795A2 (en) Catechol diether compounds as inhibitors of TNF release
JP2008527029A (ja) 炎症の治療に有用なインドール類
CZ218198A3 (cs) Nové cykloalkylem substituované imidazoly, způsob jejich přípravy, farmaceutické prostředky s jejich obsahem a způsob inhibice
EP1839655A1 (en) Ctgf expression inhibitor
AU2014366371A1 (en) Dimethylbenzoic acid compounds
KR20100016076A (ko) 신규 피롤리논 유도체 및 그것을 함유하는 의약 조성물
EP3585772B1 (en) 1, 4, 6-trisubstituted-2-alkyl-1h-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors
KR101503286B1 (ko) 벤즈이미다졸 ｔｒｐｖ1 저해제
EP3144303B1 (en) 6-substituted phenoxychroman carboxylic acid derivatives
US20040259869A1 (en) Cycloalkyl alkanoic acids as integrin receptor antagonists
WO2012012322A1 (en) Substituted hydroxamic acids and uses thereof
AU2012214413A1 (en) Method of inhibiting hamartoma tumor cells
Bai et al. Synthesis and biological evaluation of 4′-[(benzimidazole-1-yl) methyl] biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists
CA2888480A1 (en) Heteroaryl linked quinolinyl modulators of ror.gamma.t
JPH0471077B2 (cs)
Lu et al. Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
JPH04210946A (ja) 新規なアリールビニルアミド誘導体およびその製造方法
WO2010073078A2 (en) Heterocyclic compounds as hdac inhibitors
JP2022511287A (ja) ｃ－ＭＹＣ標的剤としての置換複素環化合物

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120537

Country of ref document: FI

MM Patent lapsed